Hoth Therapeutics Expands AI Capabilities with NVIDIA Platform
Hoth Therapeutics has expanded its artificial intelligence initiative by adopting the NVIDIA AI Enterprise platform, announced in a press release. This move aims to accelerate data-driven drug development, preclinical modeling, and predictive analytics.
Under the new agreement, Hoth Therapeutics has secured annual NVIDIA AI Enterprise Essentials licenses to support its GPU-powered infrastructure. This will enable advanced machine learning and neural network modeling capabilities for pharmaceutical research. The NVIDIA AI Enterprise environment will allow Hoth's teams to deploy predictive pharmacology and toxicity models, integrate multi-omic and patient-derived data, and support clinical trial simulations.
The adoption of NVIDIA's platform reflects Hoth's commitment to integrating next-generation technology across its R&D programs, enhancing the development of therapies like HT-001 and HT-KIT. This initiative complements Hoth's broader strategy of digital transformation and innovation in biotechnology.
We hope you enjoyed this article
Consider subscribing to one of our newsletters like Life AI Weekly or Daily AI Brief.
Also, consider following us on social media:
More from Life Sciences
Oct 16 Study Tests Smartphone AI for Children's Lung Sounds Oct 16 Manhattan Physician Invests in RunPractice Oct 16 Attilio appoints Buck Institute CEO Eric Verdin as cochairman Oct 16 Aignostics launches HETA Clinical for pathology workflows Oct 16 Specialty1 Partners Invests in AI for Dental Practice OperationsLife AI Weekly
Weekly coverage of AI applications in healthcare, drug development, biotechnology research, and genomics breakthroughs.
Industry analysis
2025 Global Business Services Agenda: Gen AI Takes Center Stage
This industry analysis by The Hackett Group explores the transformative impact of generative artificial intelligence (Gen AI) on global business services (GBS) in 2025. The study highlights the shift from exploration to acceleration of Gen AI initiatives, with 89% of executives advancing these projects to improve customer satisfaction, innovate products, and reduce costs. The report also discusses the challenges and strategies for successful Gen AI adoption, emphasizing the need for a technology-enabled operating model and the importance of reskilling the workforce.
Read moreYou may also like
OpenAI Offered $100 Million to Hugging Face Before NVIDIA Deal
NVIDIA Plans Investments in Four French Startups
Hansa Biopharma Partners With Cradle on AI Protein Design
NVIDIA expands stock buyback by $150 billion
Novo Nordisk Partners With Anthropic on Drug Research
Daily AI Brief: the AI news that matters, in your inbox.